SYSTEMIC RITUXIMAB FOR THE TREATMENT OF THE INDOLENT FORMS OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS: data from the Spanish Primary Cutaneous Lymphoma Registry.
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
1
Citations
NaN
KQI